Rheumatology Advance Access originally published online on October 13, 2006
Rheumatology 2007 46(4):586-589; doi:10.1093/rheumatology/kel338
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investigation of the role of ENPP1 and TNAP genes in chondrocalcinosis
Oxford University Institute of Musculoskeletal Sciences, Botnar Research Centre, Nuffield Orthopaedic Centre, Oxford, UK.
Correspondence to: Y. Zhang, Oxford University Institute of Musculoskeletal Sciences, Botnar Research Centre, Nuffield Orthopaedic Centre, Oxford OX3 7LD, UK. E-mail: yun{at}well.ox.ac.uk
| Abstract |
|---|
Objectives. Extracellular inorganic pyrophosphate (ePPi) inhibits certain forms of pathological mineralization while promoting others. Three molecules involved in ePPi regulation are important candidates for the development of calcium pyrophosphate dihydrate chondrocalcinosis (CPPD CC). These include ANKH, ectonucleotide pyrophosphatase (ENPP1) and TNAP. We have previously showed that genetic variation in ANKH is a cause of autosomal dominant familial CC and also some sporadic cases of CPPD CC. We now investigate the possible role of ENPP1 and TNAP in CPPD CC.
Methods. Exons, untranslated regions (UTR) and exonintron boundaries of ENPP1 and TNAP were sequenced using ABI Big Dye chemistry on automated sequencers. Sixteen variants were identified (3 in ENPP1 and 13 in TNAP) and were subsequently genotyped in 128 sporadic Caucasian CPPD CC patients and 600 healthy controls using a combination of polymerase chain reaction/restriction fragment-length polymorphism analysis or using Taqman. Allele and genotype frequencies were compared between cases and controls using the
2 test. Linkage disequilibrium, haplotype and the single nucleotide polymorphism-specific analyses were also performed. This study had 80% power to detect an odds ratio of 2.2 or more at these loci.
Results. No difference was observed in the allele or genotype frequencies between patients and controls at either ENPP1 or TNAP.
Conclusions. Polymorphisms of ENPP1 and TNAP are not major determinants of susceptibility to CC in the population studied. Further studies of the aetiology of sporadic CPPD CC are required to determine its causes.
KEY WORDS: Pyrophosphate arthropathy, ANKH, Pseudogout, ENPP1, TNAP
Submitted 20 April 2006;
revised version accepted 18 August 2006.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
P. Richette, T. Bardin, and M. Doherty An update on the epidemiology of calcium pyrophosphate dihydrate crystal deposition disease Rheumatology, July 1, 2009; 48(7): 711 - 715. [Abstract] [Full Text] [PDF] |
||||
